Updated Progression-Free Survival (PFS) and Overall Survival (OS) with Melflufen and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Phase 2 Study O-12-M1

Sara Bringhen; Peter M Voorhees; Torben Plesner; Ulf-Henrik Mellqvist; Brandi Reeves; Pieter Sonneveld; Catriona Byrne; Eva Nordström; Johan Harmenberg; Jakob Obermüller; Paul G Richardson

doi:10.1182/blood-2019-124828

Updated Progression-Free Survival (PFS) and Overall Survival (OS) with Melflufen and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Phase 2 Study O-12-M1

Sara Bringhen, Peter M Voorhees, Torben Plesner, Ulf-Henrik Mellqvist, Brandi Reeves, Pieter Sonneveld, Catriona Byrne, Eva Nordström, Johan Harmenberg, Jakob Obermüller, Paul G Richardson

IRS - Lillebælt Hospital, Research Unit of Haematology (Vejle)

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	1839
Journal	Blood
Volume	134
Issue number	Suppl. 1
ISSN	0006-4971
DOIs	https://doi.org/10.1182/blood-2019-124828
Publication status	Published - Nov 2019
Event	American Society of Hematology: 61st Annual Meeting (ASH) - Orlando, United States Duration: 7. Dec 2019 → 10. Dec 2019

Conference

Conference	American Society of Hematology: 61st Annual Meeting (ASH)
Country/Territory	United States
City	Orlando
Period	07/12/2019 → 10/12/2019

Documents & Links

10.1182/blood-2019-124828

Cite this

Bringhen, S., Voorhees, P. M., Plesner, T., Mellqvist, U.-H., Reeves, B., Sonneveld, P., Byrne, C., Nordström, E., Harmenberg, J., Obermüller, J., & Richardson, P. G. (2019). Updated Progression-Free Survival (PFS) and Overall Survival (OS) with Melflufen and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Phase 2 Study O-12-M1. Blood, 134(Suppl. 1), Article 1839. https://doi.org/10.1182/blood-2019-124828

@article{b2baf8c2e0444ba581bb3002728077ec,

title = "Updated Progression-Free Survival (PFS) and Overall Survival (OS) with Melflufen and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Phase 2 Study O-12-M1",

author = "Sara Bringhen and Voorhees, {Peter M} and Torben Plesner and Ulf-Henrik Mellqvist and Brandi Reeves and Pieter Sonneveld and Catriona Byrne and Eva Nordstr{\"o}m and Johan Harmenberg and Jakob Oberm{\"u}ller and Richardson, {Paul G}",

year = "2019",

month = nov,

doi = "10.1182/blood-2019-124828",

language = "English",

volume = "134",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier",

number = "Suppl. 1",

note = "American Society of Hematology: 61st Annual Meeting (ASH) ; Conference date: 07-12-2019 Through 10-12-2019",

}

Bringhen, S, Voorhees, PM, Plesner, T, Mellqvist, U-H, Reeves, B, Sonneveld, P, Byrne, C, Nordström, E, Harmenberg, J, Obermüller, J & Richardson, PG 2019, 'Updated Progression-Free Survival (PFS) and Overall Survival (OS) with Melflufen and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Phase 2 Study O-12-M1', Blood, vol. 134, no. Suppl. 1, 1839. https://doi.org/10.1182/blood-2019-124828

Updated Progression-Free Survival (PFS) and Overall Survival (OS) with Melflufen and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Results from the Phase 2 Study O-12-M1. / Bringhen, Sara; Voorhees, Peter M; Plesner, Torben et al.
In: Blood, Vol. 134, No. Suppl. 1, 1839, 11.2019.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Updated Progression-Free Survival (PFS) and Overall Survival (OS) with Melflufen and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

T2 - American Society of Hematology: 61st Annual Meeting (ASH)

AU - Bringhen, Sara

AU - Voorhees, Peter M

AU - Plesner, Torben

AU - Mellqvist, Ulf-Henrik

AU - Reeves, Brandi

AU - Sonneveld, Pieter

AU - Byrne, Catriona

AU - Nordström, Eva

AU - Harmenberg, Johan

AU - Obermüller, Jakob

AU - Richardson, Paul G

PY - 2019/11

Y1 - 2019/11

U2 - 10.1182/blood-2019-124828

DO - 10.1182/blood-2019-124828

M3 - Conference abstract in journal

SN - 0006-4971

VL - 134

JO - Blood

JF - Blood

IS - Suppl. 1

M1 - 1839

Y2 - 7 December 2019 through 10 December 2019

ER -